Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Monday ​that a late-stage trial testing ‌its multiple sclerosis drug ...

Overhyped “dream” trips sell certainty and a photo, not depth... skip the brochure script, slow down, and trade one icon for ...

The table below comprises the names of units which are part of the latest syllabus for the 2025 exams. These chapters are intact with minor additions. Discovery of Electron, Proton, and Neutron, ...

HCW11-040 expands and activates human peripheral blood lymphocytes (PBMCs) and memory T cells significantly better than pembrolizumab alone. HCW11-040 exhibits significantly better anti-tumor activity ...

The same chemical reaction that makes a piece of freshly toasted bread delicious also happens in our bodies, with far less appetizing consequences. We're talking about the Maillard reaction, where ...

It's difficult to put an exact price tag on how much index funds have saved investors since their creation in 1975. But it's ...

"Double double toil and trouble" is a quote from Shakespeare's Macbeth that conjures images of evil witches making potions in ...

The Watchdog welcomes the news that a new state law creates a requirement for all Texas public school students to take a ...

Q3 2025 Earnings Call Transcript November 10, 2025 Pagaya Technologies Ltd. misses on earnings expectations. Reported EPS is ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...